Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07079683 · ClinicalTrials.gov registry record · NA

RCT: Enzyme Blend Toothpaste on Dental Biofilm Plaque Accumulation

A NA study, sponsored by Novozymes A/S.

Completed
Registry status
NA
Development phase
132
Enrollment target

NCT07079683: Completed NA study, sponsored by Novozymes A/S.

NCT07079683 is a NA study that has completed, run by Novozymes A/S. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07079683, a NA study, has completed, sponsored by Novozymes A/S.

COMPLETED
Registry status
NA
Development phase
132 participants
Enrollment target

Study Summary

The aim of the study is to investigate whether brushing twice a day with a toothpaste (Biofresh Clean) containing a blend of alpha-amylase and gluco-amylase improves oral health outcomes over a 14-day period. The primary objective is to evaluate if the enzyme-containing toothpaste has an effect on dental plaque accumulation compared to placebo following 28 days of use. The secondary objectives are to: * Evaluate if the enzyme-containing toothpaste has an effect on dental plaque accumulation compared to placebo at Days 1 and 14 * Evaluate if the enzyme-containing toothpaste has an effect on gumline and proximal plaque severity compared to placebo at Days 1, 14 and 28 * Evaluate if the enzyme-containing toothpaste has an effect on whole mouth Gingivitis as well as gumline and proximal Gingivitis severity compared to placebo at Days 14 and 28 The exploratory variables are to investigate if the enzyme-containing toothpaste results in: * Shift in detected oral bacterial species of interest at Screening and Baseline to Days 14 and 28, based on microbial DNA-extraction and microbial whole genome sequencing compared to placebo. * Shift in immune markers (IL-1β, , IL-8 and MIF) at Screening and Baseline to Days 14 and 28, based on electrochemiluminescence assay compared to placebo. * Difference in performance attributes compared to placebo based on End of Study Post-product use questionnaire after 28 days of product use. The safety objective is to investigate safety and tolerability of brushing twice daily based on treatment emergent adverse events. Target Population Randomized subjects are generally healthy males and females (18-65y) with at least 20 natural teeth, A gingival index score of ≥ 1.0, according to the Löe-Silness Gingival Index at baseline and a plaque index score ≥ 1.95 according to the Lobene-Soparkar Modification of the Turesky Modification of the Quigley-Hein Plaque Index.. Researchers will compare Biofresh Clean Toothpaste to an identically package

Primary Outcome

Change in mean whole Mouth (WM) dental plaque accumulation assessed using the Lobene-Soparkar Modification of the Turesky Modification of the Quigley-Hein Plaque Index (PLI) with a score range from 0 to 5. A score of 0 means no plaque, while higher scores indicate increasing amounts of plaque.

Interventions

  • OTHER Toothpaste Product

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2023-10-30
Est. Completion 2023-12-13
Phase NA
Novozymes A/S

5 total trials

What the finished NCT07079683 record still lists

NCT07079683 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Toothpaste Product is the first listed.

NCT07079683 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07079683 about?

NCT07079683 is a clinical study titled "RCT: Enzyme Blend Toothpaste on Dental Biofilm Plaque Accumulation". The aim of the study is to investigate whether brushing twice a day with a toothpaste (Biofresh Clean) containing a blend of alpha-amylase and gluco-amylase improves oral health outcomes over a 14-day period. The primary objective is to evaluate if the enzyme-containing toothpaste has an effect on ...

What is the current status of trial NCT07079683?

This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2023-10-30. Estimated completion is 2023-12-13.

What interventions are being tested in trial NCT07079683?

The interventions under investigation include: Toothpaste Product (OTHER).

Who is sponsoring clinical trial NCT07079683?

This trial is sponsored by Novozymes A/S, which has 5 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07079683's enrollment target sits among peer trials

132 729th of 2000 higher than 1,269 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01766297 · 132 participants · Phase 2

    Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

  • NCT04002947 · 132 participants · Phase 2

    Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

  • NCT04128189 · 132 participants · Phase 3

    Shingrix in Renal Transplant Recipients

  • NCT04199780 · 132 participants · NA

    Effects of tDCS Combined With CBI on Postsurgical Pain

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07079683, the US trial registry maintained by the National Library of Medicine. NCT07079683 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.